Volume 18, Number 8—August 2012
Dispatch
Chloroquine-Resistant Malaria in Travelers Returning from Haiti after 2010 Earthquake
Table 2
Characteristics | Before earthquake, n = 49 | After earthquake, n = 30 |
---|---|---|
In vitro analysis | n = 24 | n = 10 |
IC50 for chloroquine, nmol/L (mean 95% CI) | 27 (23–31) | 35 (12–105)* |
No. isolates resistant† | ||
Yes |
0 | 2 |
No |
24 | 8 |
Molecular marker analysis, no. (%) isolates | n = 29 | n = 19 |
PfCRT K76 |
29 | 17 (89.5) |
PfCRT K76+76T |
0 | 2 (10.5) |
PfCRT 76T |
0 | 0 |
*The 2 resistant isolates are included with an IC50 of 506 nmol/L and 708 nmol/L. IC50, 50% inhibitory concentration.
†A threshold of IC50 = 100 nmol/L is applied to determine resistant isolates (consensus between the laboratories in France and Canada) and in vitro susceptibility (IC50) for the isolates from patients returning from Haiti.
1Members of the French National Reference Center for Imported Malaria Study who contributed data are listed at the end of this article.
Page created: July 19, 2012
Page updated: July 19, 2012
Page reviewed: July 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.